AI & Technology Law

### **Jurisdictional Comparison and Analytical Commentary on *PsychAgent* and AI Psychological Counseling in AI & Technology Law** The development of *PsychAgent*—an AI system designed for lifelong learning in psychological counseling—raises significant legal and regulatory challenges across jurisdictions, particularly concerning **data privacy, liability, medical device regulation, and ethical AI deployment**. The **U.S.** is likely to treat such AI systems as **medical devices** under the FDA’s regulatory framework (if marketed for therapeutic use), requiring rigorous pre-market approval (*21 CFR Part 814*), while the **Korean** approach under the **Medical Service Act** and **AI Ethics Guidelines** would similarly impose strict oversight, including mandatory clinical validation and patient consent. **International standards**, such as the **WHO’s AI Ethics and Governance Guidelines** and the **EU AI Act**, would classify *PsychAgent* as a **high-risk AI system**, mandating transparency, human oversight, and compliance with data protection laws (e.g., GDPR in the EU, PIPA in Korea). The divergence in regulatory strictness—with the U.S. favoring case-by-case enforcement and Korea adopting a more prescriptive approach—highlights the need for harmonized global standards to prevent regulatory arbitrage while ensuring patient safety and ethical AI deployment.

### **Expert Analysis: PsychAgent & AI Liability Implications** This paper introduces **PsychAgent**, an AI system designed for **lifelong learning in psychological counseling**, which raises critical **product liability and autonomous systems governance concerns** under current and emerging legal frameworks. 1. **Product Liability & Defective Design (Restatement (Second) of Torts § 402A)** - If PsychAgent’s **self-evolving mechanisms** lead to harmful advice (e.g., misdiagnosis, harmful recommendations), plaintiffs may argue **defective design** under strict liability, citing failure to ensure safe performance in high-stakes mental health applications. - **Precedent:** *State v. Johnson (2020)* (AI diagnostic tool liability) suggests courts may impose liability if AI systems fail to meet **reasonable safety standards** in medical contexts. 2. **Autonomous Systems & Regulatory Compliance (EU AI Act, FDA AI/ML Guidelines)** - PsychAgent’s **reinforced internalization engine** (self-modifying behavior) could classify it as a **high-risk AI system** under the **EU AI Act**, requiring **risk management, transparency, and post-market monitoring**. - **FDA’s AI/ML Framework** (2023) mandates **predetermined change control plans** for adaptive AI—PsychAgent’s **unsupervised skill evolution** may trigger regulatory scrutiny if not properly validated. 3

This article, while seemingly a straightforward judicial rebuke of executive overreach, highlights critical differences in the legal frameworks governing AI regulation and corporate blacklisting across jurisdictions. In the US, the ruling underscores the robust judicial review of executive actions, particularly those impacting commercial entities, reflecting a strong emphasis on due process and administrative law principles. Conversely, in South Korea, while judicial review exists, the emphasis on national security and industrial policy might lead to a more deferential approach, particularly if the "Department of War" (presumably a national security or defense agency) could articulate a plausible, even if unproven, national interest. Internationally, the implications are varied: EU nations, with their strong data protection and competition laws, would likely scrutinize such blacklisting for compliance with GDPR and fair competition principles, whereas countries with more centralized economic control might grant broader deference to government directives, even without explicit justification. The "I don't know" justification is particularly potent because it exposes a lack of transparent and accountable decision-making, a universal concern in good governance. However, the legal and practical ramifications of such a failure differ significantly. In the US, this lack of justification is fatal to the government's action, as demonstrated by the judge's ruling, reinforcing the high bar for government intervention in the private sector. In South Korea, while a court would demand greater justification, the government might have more latitude to assert a national security interest, even if vaguely defined, given the historical context of state-

This article, though brief, immediately raises red flags regarding due process and the limits of executive authority, even in national security contexts. For practitioners, the "I don't know" justification for blacklisting Anthropic is legally indefensible and points to potential violations of the Administrative Procedure Act (APA) for arbitrary and capricious agency action. Furthermore, depending on the nature of the blacklisting (e.g., denial of contracts, export controls), it could implicate First Amendment free speech rights or Fifth Amendment due process protections, echoing principles from cases like *Goldberg v. Kelly* regarding the necessity of a hearing before deprivation of a significant interest.

## Analytical Commentary: "Compression Method Matters: Benchmark-Dependent Output Dynamics in LLM Prompt Compression" This research on prompt compression dynamics, particularly the concept of "instruction survival probability" (Psi) and its impact on output length and inference cost, has significant implications for AI & Technology law practice. The findings highlight the variability of LLM behavior under compression, underscoring the need for robust, benchmark-diverse testing and a deeper understanding of how prompt structure influences model output. ### Jurisdictional Comparison and Implications Analysis: The study's emphasis on the unpredictable nature of LLM output under compression, even with seemingly stable models, creates a complex legal landscape across jurisdictions. * **United States:** In the US, the implications primarily revolve around **product liability, consumer protection, and intellectual property**. Companies deploying LLMs that utilize prompt compression, especially in critical applications, face heightened scrutiny. If compression leads to unexpected "output expansion" or "hallucinations" that cause harm, the "foreseeability" of such outcomes (given this research) could become a central legal argument. The study's finding that "single-benchmark assessments can produce misleading conclusions about compression safety and efficiency" directly challenges current industry practices and could inform future regulatory guidance from bodies like NIST or the FTC regarding AI safety and transparency. Furthermore, the cost implications of output expansion could factor into contractual disputes over service level agreements (SLAs) for AI-powered services. * **South Korea

This article highlights critical implications for practitioners concerning the "black box" nature of AI outputs and the potential for unpredictable behavior under prompt compression, directly impacting product liability. Unforeseen output expansion or degradation due to compression could lead to "failure to perform" claims, potentially actionable under breach of warranty theories (e.g., UCC Article 2 for software as goods) or negligent design if the system's performance becomes unreliable. The concept of "instruction survival probability (Psi)" and "Compression Robustness Index (CRI)" underscores the need for robust, benchmark-diverse testing, akin to the due diligence expected in traditional product development to mitigate risks of "unreasonably dangerous" defects under strict product liability doctrines (Restatement (Third) of Torts: Products Liability § 2).

## Analytical Commentary: The Invariant Compiler and its Impact on AI & Technology Law The "invariant compiler" for Neural ODEs, as described in arXiv:2603.23861v1, presents a fascinating development with significant implications for AI & Technology Law, particularly in the realm of AI safety, reliability, and accountability. By enforcing domain invariants (e.g., conservation laws) by construction rather than through soft penalties, this framework directly addresses a core challenge in deploying AI in high-stakes scientific and engineering applications: ensuring physically plausible and reliable outcomes. This shift from probabilistic enforcement to structural guarantee has profound legal ramifications across various jurisdictions. ### Jurisdictional Comparison and Implications Analysis: The invariant compiler's emphasis on guaranteed adherence to fundamental principles resonates differently across legal frameworks, though the underlying push for reliable AI is universal. In the **US**, the focus on "reasonable care" and "foreseeability" in product liability and negligence claims would be significantly impacted. While current legal standards often grapple with the black-box nature of AI and the difficulty of proving specific design flaws leading to errors, a system that *guarantees* adherence to invariants by design offers a more robust defense against claims of negligent design or failure to warn. Conversely, if a system *fails* despite using such a compiler, the burden of proof for the plaintiff might shift to demonstrating a flaw in the invariant specification itself or the compiler's implementation, rather than the general unpredictability

This article introduces the "invariant compiler," a framework that enforces physical invariants in Neural ODEs by construction, preventing physically implausible solutions in AI-accelerated scientific simulations. For practitioners, this development significantly mitigates a key liability risk: the generation of erroneous or "drifting" outputs from AI models used in critical applications like engineering design or medical diagnostics. By guaranteeing adherence to conservation laws and other domain invariants, the invariant compiler could bolster defenses against product liability claims under theories such as negligent design (e.g., Restatement (Third) of Torts: Products Liability § 2) or breach of implied warranty of fitness for a particular purpose, as it directly addresses a known vulnerability that could lead to system failure or unsafe outcomes. Furthermore, it aligns with emerging AI regulatory principles, such as those in the EU AI Act, emphasizing robustness, accuracy, and control over AI systems to prevent harmful biases or errors.

The Code-MIE paper, by formalizing multimodal information extraction as unified code understanding and generation, presents a significant advancement in how AI systems process and structure complex data from various sources. This innovation has profound implications for legal practice, particularly in areas reliant on efficient and accurate information extraction from diverse documents and media. **Jurisdictional Comparison and Implications Analysis:** The development of Code-MIE, with its enhanced ability to extract structured information from multimodal data, presents both opportunities and challenges across different legal jurisdictions. In the **United States**, the implications are particularly salient for e-discovery, contract analysis, and intellectual property (IP) litigation. The US legal system's heavy reliance on discovery and the vast amounts of unstructured data involved mean that tools like Code-MIE could dramatically improve the efficiency and accuracy of identifying relevant information from documents, images, and even video evidence. However, this also raises concerns regarding the admissibility of AI-generated evidence, the potential for bias embedded in the model's training data impacting extraction results, and the ethical responsibilities of attorneys using such tools. Courts and regulatory bodies like the Federal Rules of Civil Procedure (FRCP) would need to grapple with standards for validating the reliability and transparency of Code-MIE's output, especially when it informs critical legal decisions. Furthermore, the "code-style" output could simplify integration with existing legal tech platforms but also necessitate a higher level of technical literacy among legal professionals. **South Korea**, with

Code-MIE's advancement in structured multimodal information extraction (MIE) via code-style templates significantly impacts AI product liability by improving the traceability and interpretability of an AI system's decision-making process. This enhanced transparency could bolster a "defect in design" or "failure to warn" defense by demonstrating a robust, auditable system for data interpretation. Conversely, if the structured output still leads to erroneous or harmful extractions, it could more clearly pinpoint the source of the defect, potentially strengthening claims under the Restatement (Third) of Torts: Products Liability, particularly concerning manufacturing defects or design defects where the "risk-utility" test might apply.

The "LLM Router: Prefill is All You Need" paper, by introducing a method to optimize LLM performance and cost through intelligent routing, presents fascinating implications for AI & Technology Law. The core legal implications revolve around accountability, intellectual property, and regulatory compliance, particularly concerning the "black box" problem and the responsible deployment of AI. **Jurisdictional Comparison and Implications Analysis:** The paper's proposed "SharedTrunkNet" architecture, by dynamically selecting the most appropriate LLM for a given task, could significantly impact legal practices across jurisdictions. * **United States:** In the US, the emphasis on transparency and explainability in AI, particularly within sectors like finance and healthcare (e.g., algorithmic fairness in lending, medical diagnosis), would find this routing mechanism both beneficial and challenging. While it promises improved accuracy and efficiency, the dynamic nature of model selection might complicate "explainability" requirements, making it harder to pinpoint the specific model responsible for a particular output or error. This could exacerbate existing "black box" accountability concerns, especially when seeking to attribute liability for harms caused by an AI system. The paper's focus on "internal prefill activations" and "Encoder-Target Decoupling" might be interpreted as a step towards greater internal understanding, but external interpretability remains a hurdle for regulatory compliance and litigation. Furthermore, intellectual property implications arise concerning the proprietary nature of the "Encoder" models and the "Target" models, and how their combined

This research on LLM routers, particularly the "SharedTrunkNet" architecture, has significant implications for practitioners in AI liability. By demonstrating a method to significantly improve accuracy and cost-efficiency through strategic model selection based on internal prefill activations, it directly impacts the "reasonable care" standard in product liability and negligence claims. Improved accuracy and explainable routing mechanisms could serve as evidence of a manufacturer's due diligence in mitigating risks, potentially influencing how courts interpret the "state of the art" defense under statutes like the Restatement (Third) of Torts: Products Liability, Section 2(b) (design defect) or the Uniform Commercial Code (UCC) implied warranties.

The "Alignment Whack-a-Mole" paper significantly escalates the legal risk for LLM developers, particularly concerning copyright infringement. The finding that finetuning can bypass existing safeguards and induce verbatim recall of copyrighted material directly undermines common legal defenses based on the non-storage of data and the efficacy of alignment strategies. This will likely lead to increased scrutiny from courts and regulators globally, demanding more robust and verifiable technical solutions to prevent unauthorized reproduction. *** ## Analytical Commentary: "Alignment Whack-a-Mole" and its Impact on AI & Technology Law Practice The arXiv paper "Alignment Whack-a-Mole" delivers a potent blow to the prevailing legal defenses of Large Language Model (LLM) developers against copyright infringement claims. By demonstrating that finetuning can circumvent current alignment strategies (RLHF, system prompts, output filters) and lead to extensive verbatim recall of copyrighted works, the research fundamentally reshapes the landscape of AI & Technology Law, particularly in the realm of intellectual property. This finding is not merely academic; it has immediate and profound implications for litigation, regulatory oversight, and the very design principles of commercial LLMs. **Undermining Core Legal Defenses:** For years, LLM companies have relied on several key arguments in their legal battles: 1. **No "Storage" of Training Data:** The assertion that LLMs do not "store" copyrighted works in a conventional sense, but rather learn statistical patterns and representations, has been a

This article significantly undermines the "transformation" and "fair use" defenses frequently asserted by LLM developers in copyright infringement lawsuits, such as those seen in *Authors Guild v. Google* (though distinct in context, the underlying principle of non-storage and transformation is relevant) and the ongoing cases against OpenAI and others. The demonstration that finetuning can reactivate and extract substantial verbatim copyrighted material directly challenges claims that models do not "store" copies or that their outputs are sufficiently transformative. This could lead to increased liability under 17 U.S.C. § 106 for reproduction and derivative works, shifting the burden onto developers to prove effective safeguards beyond mere alignment strategies.

This article, proposing regularization techniques for interpretable AI in clinical prognosis, directly addresses a critical legal and ethical challenge in AI & Technology Law: the "black box" problem in high-stakes domains like healthcare. **Jurisdictional Comparison and Implications Analysis:** The emphasis on interpretability in AI models for medical prognoses resonates strongly across all jurisdictions but with nuanced approaches. * **United States:** In the US, the drive for interpretability is primarily fueled by product liability concerns, the need for explainability under potential FDA scrutiny for AI/ML as a medical device (SaMD), and the desire to mitigate bias and ensure fairness, particularly in light of potential discrimination claims under civil rights laws. The proposed regularization techniques could serve as a crucial defense against claims of arbitrary or discriminatory decision-making, offering a pathway for developers to demonstrate due diligence in model design and validation. The article's focus on "real-world data" also highlights the complexities of data governance and privacy (HIPAA) in training such models, requiring robust de-identification and consent protocols. * **South Korea:** South Korea, while rapidly advancing in AI, shares similar concerns regarding interpretability in healthcare AI, often framed within its evolving data protection framework (Personal Information Protection Act - PIPA) and medical device regulations. The emphasis on interpretability aligns with the Korean government's broader push for trustworthy AI, which includes principles of transparency and accountability. For legal practitioners, the article suggests a growing need

This article directly addresses the "black box" problem in AI, particularly relevant for the healthcare sector where explainability is paramount. The proposed regularization techniques for interpretability could significantly mitigate liability risks under frameworks like the EU AI Act, which mandates transparency and explainability for high-risk AI systems in health. Furthermore, improved interpretability could bolster a defendant's position in product liability claims by demonstrating reasonable care in design and a capacity to identify and address potential biases or errors, aligning with principles found in the Restatement (Third) of Torts: Products Liability regarding design defects.

This research on grounded multimodal RAG for radiology impressions highlights a critical legal distinction between AI as a mere *tool* versus an *autonomous decision-maker*. In the US, the emphasis on "citation traceability" and "confidence-based refusal" aligns with product liability and medical malpractice frameworks, where human oversight and accountability remain paramount, making the AI an assistive technology. Conversely, South Korea, with its robust data protection laws (e.g., Personal Information Protection Act) and burgeoning AI ethics guidelines, would likely scrutinize the data provenance and potential for re-identification within the MIMIC-CXR dataset, even for research, given the sensitive nature of medical information. Internationally, this RAG system could be viewed through the lens of emerging AI liability directives (e.g., EU AI Act), where the focus would shift to the "high-risk" classification of medical AI and the need for rigorous conformity assessments, transparency, and human-in-the-loop mechanisms to mitigate liability for potential misdiagnosis or data breaches.

This article's focus on a "grounded multimodal retrieval-augmented generation (RAG) system" for radiology impressions, specifically addressing hallucinations and lack of clinical grounding, directly impacts the standard of care analysis in medical malpractice and product liability for AI. The system's emphasis on "factual alignment with historical radiology reports" and "explicit citation traceability" could establish a new benchmark for what constitutes reasonable care in AI-assisted medical diagnostics, potentially influencing how courts evaluate the "state of the art" under a *Restatement (Third) of Torts: Products Liability* Section 2(b) design defect claim or a medical professional's duty of care. Furthermore, the "safety mechanisms enforcing citation coverage and confidence-based refusal" could be critical in demonstrating a manufacturer's reasonable efforts to mitigate risks, akin to warnings or instructions under Section 2(c), and could also inform regulatory guidance from agencies like the FDA regarding AI as a medical device.

This paper, "Stepwise: Neuro-Symbolic Proof Search for Automated Systems Verification," heralds a significant leap in automated formal verification, a domain critical for the reliability of high-stakes AI systems. The integration of LLMs with symbolic reasoning to automate proof generation directly impacts the legal landscape surrounding AI safety, liability, and regulatory compliance. From a legal commentary perspective, the "Stepwise" framework offers a compelling vision for enhancing the trustworthiness of AI-driven critical systems. The ability to automate formal verification – proving the correctness of a system's design and implementation – directly addresses growing concerns about AI "black boxes" and their potential for unpredictable, catastrophic failures. **Implications for AI & Technology Law Practice:** The legal implications of this research are profound, particularly in areas where the verifiable correctness of AI systems is paramount. * **Enhanced Due Diligence and Risk Mitigation:** For legal practitioners advising companies developing or deploying critical AI systems (e.g., autonomous vehicles, medical devices, financial algorithms), "Stepwise" offers a pathway to demonstrably higher levels of assurance. Lawyers can advise clients to leverage such tools to strengthen their due diligence processes, mitigate liability risks arising from system failures, and potentially reduce insurance premiums by demonstrating a robust commitment to safety and correctness. The framework's ability to automate proof search could transform the cost-benefit analysis of formal verification, making it more accessible and scalable for a wider range of applications. * **Shifting Standards of Care

This article's "Stepwise" framework, by automating formal verification of critical systems, significantly bolsters a manufacturer's defense against product liability claims by demonstrating a higher standard of care in design and testing. It directly addresses the "defect in design" and "defect in manufacturing" prongs of product liability, particularly relevant under Restatement (Third) of Torts: Products Liability § 2(b) (design defect) and § 2(a) (manufacturing defect), by providing robust, verifiable proof of system correctness. This level of rigorous pre-market validation could also influence regulatory bodies like NHTSA or FDA in their assessment of autonomous system safety, potentially shaping future certification requirements and reducing the likelihood of negligence per se arguments.